dr joseph harding dihexa - Enterprise Technology & Transformation Leader | AI & Technology Strategist | Systems Thinker Stem cell, Granulocyte-Colony Stimulating Factor

Your body detoxifies this easily through rhodanese enzyme systems that convert cyanide to thiocyanate for urinary excretion

BPC-157 may enhance fibroblast activity, support collagen synthesis, influence angiogenesis, and upregulate skeletal muscle protein synthesis, making it effective for healing musculoskeletal injuries

Untreated Controls Preclinical injury models % reduction in healing time Tendon Transection (Rat Achilles model)50% Skin Wound Closure (Alkali burn model)45% Muscle Crush Injury (Rat quadriceps)40% Safety Data Safety Profile from Research What preclinical and early clinical studies report Preclinical Safety Summary LD50Not achieved Acute toxicityNone observed Chronic toxicityNone in 6-month studies Organ toxicityNone detected Human IV pilot (n=2)No adverse effects Cardiac/hepatic/renalNo effects detected Regulatory & Risk Considerations FDA statusUnapproved drug WADA statusBanned since 2022 (S0) Human trialsPhase 1 only Long-term effectsUnknown in humans Pro-angiogenic riskTheoretical unstudied Australia/NZPrescription only No lethal dose was reached in preclinical toxicology studies

Are you a fan of vitamin B12 for its energy-boosting perks